Ultra-Low Cost Product Development: The Digest’s 2016 8-Slide Guide to DMC

December 26, 2016 |

DMC’s technology enables reproducibility and robustness to scale; Production of a diversity of targets using a single bioprocess; HTS approaches that translate to full scale performance — and the company says, “50X improvement in speed and cost of product development.” The business model? Specialty chemicals, nutrition products, and pharmaceuticals, with a focus on partner agreements to quickly generate revenue and validate the technology; eventually, commercialization through strategic partnerships and existing supply chains.

DMC CEO Matt Lipscomb gave this illuminating presentation at ABLC Next 2016 in San Francisco.


Prev1 of 12
Use your ← → (arrow) keys to browse

Print Friendly, PDF & Email


Category: 8-Slide Guide

Thank you for visting the Digest.